Stroke News

Age at pediatric stroke has a significant impact on post-stroke recovery and affects long-term cognitive outcome regardless of lesion size and lesion location, according to results of a cross-sectional study published in Neurology.

Among Japanese outpatients with CV risk factors, the biomarker growth differentiation factor-15 was linked with increased risk for all-cause death and stroke events, researchers reported.

Researchers observed differences in survival between antiseizure medications in post-stroke epilepsy, with lamotrigine and levetiracetam appearing to be reasonable first-line treatment options, according to a study in JAMA Neurology.

Anticoagulation with rivaroxaban for patients with atrial fibrillation aged 65 years or more was associated with greater risk for major ischemic and hemorrhagic events compared with apixaban, according to data published in JAMA.

Pregnant women with a physical, intellectual or sensory disability had a significantly higher risk for adverse outcomes compared with pregnant women without a disability, according to findings published in JAMA Network Open.

The American Heart Association announced a $10 million initiative to fund studies of long-term effects of COVID-19 on heart and brain health.

A new classification system accurately predicted which patients with ischemic stroke of unknown original might benefit from patent foramen ovale closure.

Patients who present with a low Alberta Stroke Program Early Computed Tomography Score may achieve functional independence following mechanical thrombectomy, according to results of a retrospective cohort study.

Dual antiplatelet therapy that combined aspirin with either ticagrelor or clopidogrel outperformed aspirin alone in minor ischemic stroke and transient ischemic attack, according to results of a network meta-analysis.

Men and women with ischemic stroke had improved functional outcomes in the past 2 decades, likely due in part to the development of acute reperfusion therapy, according to results of a prospective, registry cohort study.